Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|May 21, 2021
Persistent neuropathy among early-stage breast cancer survivors in a population-based cohortKristina Engvall, Henrik Gréen, Mats Fredriksson, et al.
BMC Cancer|August 21, 2012
Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascitesMy Wintzell, Elisabet Hjerpe, Elisabeth Åvall Lundqvist, et al.
Lakartidningen|December 10, 2015
[Individualized treatment for ovarian cancer may become possible]Preben Kjölhede, Pernilla Dahm-Kähler, Bengt Tholander, et al.
Journal of Gastrointestinal Oncology|September 21, 2020
Real world aspects of palliative trifluridine plus tiperacil (TAS-102) in refractory metastatic colorectal cancerMikael Wallander, Bo Rolander, Elisabeth Åvall-Lundqvist, et al.
Acta Oncologica (Stockholm, Sweden)|January 12, 2019
Pattern of endocrine treatment for epithelial ovarian cancer in the Southeast medical region of Sweden: a population-based studyEbba Bagge, Ulrica Beiron, Susanne Malander, et al.
Lakartidningen|December 10, 2015
[Hope for improvement of survival in ovarian cancer]Thomas Högberg, Kjell Bergfeldt, Christer Borgfeldt, et al.
NPJ Precision Oncology|May 16, 2024
Prediction models of persistent taxane-induced peripheral neuropathy among breast cancer survivors using whole-exome sequencingKristina Engvall, Hanna Uvdal, Niclas Björn, et al.
European Journal of Cancer (Oxford, England : 1990)|May 3, 2017
Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trialSahar Salehi, Elisabeth Åvall-Lundqvist, Berit Legerstam, et al.
Breast Cancer Research and Treatment|August 8, 2022
Impact of persistent peripheral neuropathy on health-related quality of life among early-stage breast cancer survivors: a population-based cross-sectional studyKristina Engvall, Henrik Gréen, Mats Fredrikson, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 15, 2019
Lymphedema, serious adverse events, and imaging 1 year after comprehensive staging for endometrial cancer: results from the RASHEC trialSahar Salehi, Elisabeth Åvall-Lundqvist, Yvonne Brandberg, et al.
Pageof 6